June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Trastuzumab deruxtecan in HER2+ gastric cancer overviewed by Arndt Vogel
May 17, 2024, 16:09

Trastuzumab deruxtecan in HER2+ gastric cancer overviewed by Arndt Vogel

Arndt Vogel, managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared a post on X:

Trastuzumab deruxtecan in HER2+ gastric cancer

exploratory biomarker analysis of DESTINY Gastric01

64% concordance btw HER2+ IHC and blood
MET, EGFR and FGFR2 GA: ORR low
HER2 mutations: ORR high
activity in Her2 low.

Arndt Vogel

Read further.
Source: Arndt Vogel/X